Wednesday 30 November 2016

Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer

(NYU Langone Medical Center / New York University School of Medicine) When combined with psychological counseling, a single dose of a mind-altering compound contained in psychedelic mushrooms significantly lessens mental anguish in distressed cancer patients for months at a time, according to results of a clinical trial led by researchers at NYU Langone Medical Center.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2fTDlEF

No comments:

Post a Comment